EU to negotiate major vaccine contract extension with Pfizer
The Hindu
“We need to focus on the technologies that have proven their worth.”
EU Commission chief Ursula von der Leyen announced plans Wednesday for a major contract extension for COVID-19 vaccines with Pfizer stretching to 2023. In a sign of confidence in a company that has been a mainstay of Europe's vaccination drive so far, Ms. von der Leyen said the EU will start negotiating to buy 1.8 billion doses of the Pfizer-BioNTech vaccine through 2023. Ms. von der Leyen expressed full confidence in the technology used for the Pfizer-BioNTech vaccine, which is different from the one used for the Oxford-AstraZeneca vaccine.More Related News